CATEGORY A · A-26Intermediate

(6R,10S)-10-Amino-1-(difluoromethyl)-1,4,7,8,9,10-hexahydro-6-methyl-11,15-metheno-15H-pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one

(6R,10S)-10-氨基-1-(二氟甲基)-1,4,7,8,9,10-六氢-6-甲基-11,15-甲基-15H-吡唑并[4,3-b][1,7]二氮杂环四烯-5(6H)-酮
CAS Registry No.
1802431-24-8
Terminal API
Milvexian(BMS-986177)
Molecular Weight
335.35
Product Type
Intermediate

Identification & Structure

Chemical structure of (6R,10S)-10-Amino-1-(difluoromethyl)-1,4,7,8,9,10-hexahydro-6-methyl-11,15-metheno-15H-pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
2D Structure

C[C@@H]1CCC[C@@H](C2=NC=CC(=C2)C3=C(C=NN3C(F)F)NC1=O)N

Product CodeA-26
Product TypeIntermediate
CAS Number1802431-24-8
Molecular FormulaC16H19F2N5O
Molecular Weight335.35
IUPAC Name(9R,13S)-13-amino-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
SMILESC[C@@H]1CCC[C@@H](C2=NC=CC(=C2)C3=C(C=NN3C(F)F)NC1=O)N
InChIKeySJFDPTNYLWIEKA-KOLCDFICSA-N
PubChem CID118277795
Quality ParametersSpecification per batch COA, available on request

Related Terminal API

Listed in our catalog as an intermediate related to Milvexian(BMS-986177). Specification, available documents and lead time are confirmed with the manufacturer for each inquiry.

Direct Inquiries

Request a Quote & Documents

Tell us the quantity, specification and destination. We will reply by email with pricing, lead time and the documents available.

· Email: inquiry@candidpharm.com
· We will reply by email
· Mutual NDA available on request

Documents on Request

  • Batch Certificate of Analysis (COA)
  • Safety Data Sheet (SDS / MSDS)
  • Regulatory documents, subject to manufacturer

Patent Notice

Products listed on this site that are protected by valid patents are not offered for sale in any country where such sale would infringe those patents. Buyers are solely responsible for determining the patent status of any product in their jurisdiction. Where applicable, supply is limited to research purposes or to jurisdictions in which the relevant patents have expired or do not apply.